Medical Device Market Opportunities in Spain, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Spanish medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Spain. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014.
Coverage in This Report:
Key Population Data, Trends, Indicators (2007-2014)
Key E...
Despite continued economic challenges, the global market for small joint implants and extremities\' hardware will experience healthy growth through 2017. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare.
In the U.S., growth will be influenced by the continued ado...
This report includes details on 140 companies that: presented at LSI\'s Q1 2011 Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team in Q1 2011.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on most of the companies. Executive summaries typically include:
• Company Contact Information
• Company Overview (structure, size, year founded, etc.)...
This report includes details on 115 companies that: presented at LSI\'s Q2 2011 Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team in Q2 2011.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on some of the companies. Executive summaries typically include:
• Company Contact Information
• Company Overview (structure, size, year founded, etc.)...
This report includes details on 86 companies that: presented at LSI\'s Q3 2011 Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team in Q3 2011.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on some of the companies. Executive summaries typically include:
• Company Contact Information
• Company Overview (structure, size, year founded, etc.)...
The global market for vascular closure devices, analyzed in a new report by Life Science Intelligence, will be influenced by a mix of opposing forces through 2015, when sales are expected to reach more than $800 million. Traditionally concentrated in the U.S. and Western Europe, these devices, which include implantable technologies and external compression products, have received broad adoption during cardiac catheterization procedures. Despite their ability to replace or augment manual compre...
This report includes details on 67 companies that: presented at LSI\'s Q4 2011 Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team in Q4 2011.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on some of the companies. Executive summaries typically include:
• Company Contact Information
• Company Overview (structure, size, year founded, etc.)...
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
This report includes details on over 300 companies that: presented at a 2010 LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI\'s in-house research team in 2010.
All companies include technology, market(s), key executive, and contact information.
Two- to three-page executive summaries are provided on most of the companies. Executive summaries typically include:
• Company Contact Information
• Company Overview (structure, size, year founded, etc.)...
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
In 2009, the global market for neonatal hearing screening technologies reached $76.2 million. The U.S. accounted for the majority of these revenues, as neonatal hearing screening programs have been broadly adopted in the country. Heavy growth is expected through 2013, however, due to several factors including increased adoption in Europe, Asia-Pacific and other ROW countries.
This new report provides a global analysis of the neonatal hearing screening technologies market with detailed geo...
Brazil, Russia, India, and China (BRIC) represent attractive markets for neonatal care technologies due to favorable demographics and the growing adoption of advanced technologies. The markets in these countries present unique challenges, however, and are characterized by the presence of local and regional suppliers, the availability of low-price products, and different levels of access to healthcare resources. The combined market for neonatal care technologies in the BRIC countries were $98.2...
Chronic heart failure (HF) remains a significant untapped market in the U.S. Although numerous innovative technologies have been investigated over the past 5 years, most have lacked the effectiveness to warrant broad adoption, or complex regulatory requirements-set against a tight capital environment-have delayed or slowed their commercialization. In addition, sophisticated ventricular assist devices and total artificial hearts target patients with advanced disease, who represent a small share o...
The global market for small joint implants will experience healthy growth through 2015. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare.
In the U.S., growth will be influenced by the adoption of products that have only been available overseas, preference for mot...
The market for breast cancer detection, diagnosis, and treatment is well-developed in the U.S. and much of Europe. It has remained relatively under-developed in the Asia-Pacific region, however, although recent trends suggest that the opportunities for device manufacturers are improving, driven by the growing prevalence of breast disease in these countries.
In the U.S. and Europe, mammography is the standard of care for the early detection of breast cancer. Broader adoption is expected in...